rs112845472 - FAM171A1
Magnitude 4.5 · 1 study on file
Reported associations
-
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network - Unknown journal (n.d.) · Unknown authors · PubMed 31311600
ABSTRACT: Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver illness with a genetically heterogeneous background that can be accompanied by considerable morbidity and attendant health care costs. The pathogenesis and progression of NAFLD is complex with many unanswered questions. We conducted genome-wide association studies (GWASs) using both adult and pediatric participants from the Electronic Medical Records and Genomics (eMERGE) Network to identify novel genetic contributors to this condition. Methods First, a natural language processing (NLP) algorithm was developed, tested, and deployed at each site to identify 1106 NAFLD cases and 8571 controls and histological data from liver tissue in 235 available participants. These include 1242 pediatric participants
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Diet
-
refined carbohydrates and added sugars Moderate
High glycemic diet worsens hepatic fat accumulation in genetically susceptible individuals
limit refined grains, sugary beverages; emphasize whole foods
Lifestyle
-
maintain healthy body weight Moderate
NAFLD susceptibility with rs112845472-A is compounded by excess body weight; weight loss reduces fatty liver burden
aim for BMI <25 if overweight; discuss targets with healthcare provider
Screening
-
liver ultrasound for fatty liver disease Moderate
rs112845472-A allele confers 2-fold increased NAFLD risk; early detection enables intervention
baseline liver ultrasound or transient elastography if not previously done